Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003537356 | SCV001079055 | likely benign | Familial adenomatous polyposis 1 | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001181770 | SCV001346973 | likely benign | Hereditary cancer-predisposing syndrome | 2020-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001181770 | SCV002659191 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478585 | SCV004219650 | likely benign | not provided | 2023-03-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003983282 | SCV004800252 | likely benign | APC-related condition | 2024-02-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |